California bill that would require drug makers to report and justify price hikes took a big step toward reality on Monday night. The state Assembly overwhelmingly passed the legislation and it now goes to the Senate for approval, which legislative sources say may occur as soon as today.
The California State Assembly on Monday overwhelmingly approved Senate Bill 17, controversial legislation that could soon become the nation’s most comprehensive law aimed at shining a light on prescription drug prices.
Californians now pay more for their prescription drugs than they do for their doctors. The state spent a whopping $4 billion on drugs in 2015, and pharmaceutical companies are pushing another 12 percent increase in 2017.
Assemblyman Chad Mayes, Assemblyman Eduardo Garcia and Sen. Jeff Stone – who all represent parts of the Coachella Valley in the Legislature – play a crucial role in the fight against cancer by passing laws that help reduce the toll of cancer, which will claim nearly 60,000 lives in California this year alone.
In response to some health insurers leaving the individual market, state lawmakers are considering a bill that would ensure continuity of care for people with complex health conditions. The measure would require a new insurance firm to cover the providers of qualifying patients, even if the provider isn't in the insurer's network.
Led by their trade group, the Pharmaceutical Research and Manufacturers of America, drugmakers insist that they have consumers’ best interests at heart and warn that over-regulation would hamper their ability to deliver life-saving drugs.